NanoViricides Inc. (NNVC)

[drkazmd65]

"we can develop drug candidates against new virus targets very quickly" ~Nano Doc circa 2009

Query - what about this statement is incorrect?

Fact is - they can develop antiviral drug candidates extremely quickly - if they can figure out what target ligand the Virus is mimicing to gain entrance into a cell.

Modeling 3D structures for proteins and glycoproteins is straignfoward.

One of the keys to NNVC/Theracor's system is that the PEG backbond is a generalist polymer - it's the ligands bound to that ploymer that give the 'Cides their target specificity.

The problem isn't that developing new drug candidates is a lengthy process - they already have develped targets for a MERSCide - if they can get clearance to test it out.

The problem is the more general delay in scaling up production of the Flucide candidate, and moving through the FDA regulatory hoops.

Don't conflate the logistical problems in working through approval with the straightforward process of developing new candidate drugs.